The American Association for Cancer Research and Bayer announced the 2016 AACR-Bayer Innovation and Discovery Grants program for meritorious projects that examine novel targets and biomarkers in oncology research.
The grants will promote the Bayer Grants4Targets initiative, originally introduced in 2009, to provide new treatment options for cancers with high unmet medical need, encourage innovation and translation of ideas from basic research into novel drugs, and foster collaborations between academic groups and the pharmaceutical industry.
The research proposed for funding should examine novel therapeutic targets focusing on the following oncology research areas: inhibition of cell proliferation; survival signaling; transcription and chromatin modulation; cell cycle regulation; tumor metabolism; hypoxia; immunotherapy; and antibody-drug conjugates.
Each grant will provide $10,000 to $25,000 over a period of one year, with the grant term to begin July 1. All the recipients will be offered the opportunity to work with a Bayer mentor who will provide guidance, expertise, and/or tools to accelerate the translation of their scientific idea.
To complete an application, please visit http://myaacr.aacr.org. Applications must be submitted by Jan. 18. Additional inquiries may be directed to Shaun Fitzpatrick at grants@aacr.org.
